159 related articles for article (PubMed ID: 17091325)
1. Retrograde approach for device closure of muscular ventricular septal defects in children and adolescents, using the Amplatzer muscular ventricular septal defect occluder.
Jameel AA; Arfi AM; Arif H; Amjad K; Omar GM
Pediatr Cardiol; 2006; 27(6):720-8. PubMed ID: 17091325
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter closure of congenital muscular ventricular septal defect.
Arora R; Trehan V; Thakur AK; Mehta V; Sengupta PP; Nigam M
J Interv Cardiol; 2004 Apr; 17(2):109-15. PubMed ID: 15104774
[TBL] [Abstract][Full Text] [Related]
3. Retrograde transcatheter closure of ventricular septal defects in children using the Amplatzer Duct Occluder II.
Koneti NR; Penumatsa RR; Kanchi V; Arramraj SK; S J; Bhupathiraju S
Catheter Cardiovasc Interv; 2011 Feb; 77(2):252-9. PubMed ID: 20578168
[TBL] [Abstract][Full Text] [Related]
4. Retrograde closure of perimembranous ventricular septal defect using muscular ventricular septal occluder: a single-center experience of a novel technique.
Muthusamy K
Pediatr Cardiol; 2015 Jan; 36(1):106-10. PubMed ID: 25139246
[TBL] [Abstract][Full Text] [Related]
5. Transcatheter closure of single muscular ventricular septal defects using the amplatzer muscular VSD occluder: initial results and technical considerations.
Hijazi ZM; Hakim F; Al-Fadley F; Abdelhamid J; Cao QL
Catheter Cardiovasc Interv; 2000 Feb; 49(2):167-72. PubMed ID: 10642766
[TBL] [Abstract][Full Text] [Related]
6. Directly ventricular septal defect closure without using arteriovenous wire loop: Our adult case series using transarterial retrograde approach.
Pekel N; Ercan E; Özpelit ME; Özyurtlu F; Yılmaz A; Topaloğlu C; Saygı S; Yakan S; Tengiz İ
Anatol J Cardiol; 2017 Jun; 17(6):461-468. PubMed ID: 28315566
[TBL] [Abstract][Full Text] [Related]
7. Transcatheter closure of a mid-muscular ventricular septal defect with an amplatzer VSD occluder device.
Tofeig M; Patel RG; Walsh KP
Heart; 1999 Apr; 81(4):438-40. PubMed ID: 10092576
[TBL] [Abstract][Full Text] [Related]
8. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry.
Holzer R; Balzer D; Cao QL; Lock K; Hijazi ZM;
J Am Coll Cardiol; 2004 Apr; 43(7):1257-63. PubMed ID: 15063439
[TBL] [Abstract][Full Text] [Related]
9. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children.
Thanopoulos BD; Tsaousis GS; Konstadopoulou GN; Zarayelyan AG
J Am Coll Cardiol; 1999 Apr; 33(5):1395-9. PubMed ID: 10193744
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
Carminati M; Butera G; Chessa M; Drago M; Negura D; Piazza L
Am J Cardiol; 2005 Dec; 96(12A):52L-58L. PubMed ID: 16399093
[TBL] [Abstract][Full Text] [Related]
11. Clinical Experience of Transcatheter Closure for Residual Ventricular Septal Defect in Pediatric Patients.
Zhou W; Li F; Fu L; Gao W; Guo Y; Liu T; Huang M; Zhang Y
Congenit Heart Dis; 2016 Jul; 11(4):323-31. PubMed ID: 27029420
[TBL] [Abstract][Full Text] [Related]
12. Transcatheter trans-septal antegrade closure of muscular ventricular septal defects in young children.
Koneti NR; Verma S; Bakhru S; Vadlamudi K; Kathare P; Penumatsa RR; Qureshi S
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E500-6. PubMed ID: 23704080
[TBL] [Abstract][Full Text] [Related]
13. Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects.
Szkutnik M; Qureshi SA; Kusa J; Rosenthal E; Bialkowski J
Heart; 2007 Mar; 93(3):355-8. PubMed ID: 16980519
[TBL] [Abstract][Full Text] [Related]
14. Transcatheter closure of congenital and acquired muscular ventricular septal defects using the Amplatzer device.
Chessa M; Carminati M; Cao QL; Butera G; Giusti S; Bini RM; Hijazi ZM
J Invasive Cardiol; 2002 Jun; 14(6):322-7. PubMed ID: 12042624
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of the transcatheter closure of perimembranous and muscular ventricular septal defects with the Amplatzer duct occluder II].
Zhao PJ; Yu ZQ; Gao W; Li F; Fu LJ; Liu TL; Li Y; Zhang YQ; Huang MR; Guo Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Oct; 40(10):817-20. PubMed ID: 23302666
[TBL] [Abstract][Full Text] [Related]
16. Percutaneous closure of congenital and acquired ventricular septal defects--considerations on selection of the occlusion device.
Michel-Behnke I; Le TP; Waldecker B; Akintuerk H; Valeske K; Schranz D
J Interv Cardiol; 2005 Apr; 18(2):89-99. PubMed ID: 15882154
[TBL] [Abstract][Full Text] [Related]
17. Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder.
Thanopoulos BD; Rigby ML
Heart; 2005 Apr; 91(4):513-6. PubMed ID: 15772216
[TBL] [Abstract][Full Text] [Related]
18. Transient renal failure due to hemolysis following transcatheter closure of a muscular VSD using an Amplatzer muscular VSD occluder.
Spence MS; Thomson JD; Weber N; Qureshi SA
Catheter Cardiovasc Interv; 2006 May; 67(5):663-7. PubMed ID: 16575921
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous transcatheter ventricular septal defect closure in adults with Amplatzer septal occluders.
Marinakis A; Vydt T; Dens J; Gewillig M; Van Deyk K; Budts W
Acta Cardiol; 2007 Aug; 62(4):391-5. PubMed ID: 17824300
[TBL] [Abstract][Full Text] [Related]
20. Transcatheter Closure of Residual and Iatrogenic Ventricular Septal Defects: Tertiary Center Experience and Outcome.
Taha FA; Alnozha F; Amoudi O; Almutairi M; Abuelatta R
Pediatr Cardiol; 2022 Feb; 43(2):308-323. PubMed ID: 34495353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
